Incomplete Penetrance and Variable Expressivity: From Clinical Studies to Population Cohorts
Open accessThe DOI matches its Crossref record; 331 of the 331 references it cites were found in a registry or an index.
Abstract
The same genetic variant found in different individuals can cause a range of diverse phenotypes, from no discernible clinical phenotype to severe disease, even among related individuals. Such variants can be said to display incomplete penetrance, a binary phenomenon where the genotype either causes the expected clinical phenotype or it does not, or they can be said to display variable expressivity, in which the same genotype can cause a wide range of clinical symptoms across a spectrum. Both incomplete penetrance and variable expressivity are thought to be caused by a range of factors, including common variants, variants in regulatory regions, epigenetics, environmental factors, and lifestyle. Many thousands of genetic variants have been identified as the cause of monogenic disorders, mostly determined through small clinical studies, and thus, the penetrance and expressivity of these variants may be overestimated when compared to their effect on the general population. With the wealth of population cohort data currently available, the penetrance and expressivity of such genetic variants can be investigated across a much wider contingent, potentially helping to reclassify variants that were previously thought to be completely penetrant. Research into the penetrance and expressivity of such genetic variants is important for clinical classification, both for determining causative mechanisms of disease in the affected population and for providing accurate risk information through genetic counseling. A genotype-based definition of the causes of rare diseases incorporating information from population cohorts and clinical studies is critical for our understanding of incomplete penetrance and variable expressivity. This review examines our current knowledge of the penetrance and expressivity of genetic variants in rare disease and across populations, as well as looking into the potential causes of the variation seen, including genetic modifiers, mosaicism, and polygenic factors, among others. We also considered the challenges that come with investigating penetrance and expressivity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Christensen, D. L., Baio, J., Braun, K. V. N., Bilder, D., Charles, J., Constantino, J. N., Daniels, J., Durkin, M. S., Fitzgerald, R. T., Kurzius-Spencer, M., et al. (2016) · MMWR. Surveillance Summaries · doi:10.15585/mmwr.ss6503a1 · Cited by 1,964
RetractedA global reference for human genetic variation
The 1000 Genomes Project Consortium, authors, C., Auton, A., Abecasis, G. R., Steering committee, Altshuler, D. M., Durbin, R. M., Abecasis, G. R., Bentley, D. R., Chakravarti, A., et al. (2015) · Nature · doi:10.1038/nature15393 · Cited by 18,247
An integrated encyclopedia of DNA elements in the human genome
The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072
Analysis of protein-coding genetic variation in 60,706 humans
Exome Aggregation Consortium, Lek, M., Karczewski, K. J., Minikel, E. V., Samocha, K. E., Banks, E., Fennell, T., O’Donnell-Luria, A. H., Ware, J. S., Hill, A. J., et al. (2016) · Nature · doi:10.1038/nature19057 · Cited by 9,587
DeJesus-Hernandez, M., Mackenzie, I. R., Boeve, B. F., Boxer, A. L., Baker, M., Rutherford, N. J., Nicholson, A. M., Finch, N. A., Flynn, H., Adamson, J., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.011 · Cited by 4,936
Genetic effects on gene expression across human tissues
GTEx Consortium (2017) · Nature · doi:10.1038/nature24277 · Cited by 4,036
Buniello, A., MacArthur, J. A. L., Cerezo, M., Harris, L. W., Hayhurst, J., Malangone, C., McMahon, A., Morales, J., Mountjoy, E., Sollis, E., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1120 · Cited by 4,000 · cited 1×
“Genome-wide association studies (GWAS) have uncovered thousands of susceptibility loci for hundreds of diseases (Buniello et al., 2019), suggesting that the polygenic background can either predispose (Fahed et al., 2020) or protect individuals from diseases (Chami et al., 2020).”
BackgroundFry, A., Littlejohns, T. J., Sudlow, C., Doherty, N., Adamska, L., Sprosen, T., Collins, R., & Allen, N. E. (2017) · American Journal of Epidemiology · doi:10.1093/aje/kwx246 · Cited by 3,979
Antoniou, A., Pharoah, P. D. P., Narod, S., Risch, H. A., Eyfjord, J. E., Hopper, J. L., Loman, N., Olsson, H., Johannsson, O., Borg, Å., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/375033 · Cited by 3,680 · cited 1×
“Meta-analysis studies have shown that the cumulative breast cancer risks for BRCA1 and BRCA2 pathogenic variant carriers by age 70 are 57–65% and 45–49%, respectively (Antoniou et al., 2003; Chen and Parmigiani, 2007), highlighting the difficulties with predicting the course of disease even in known pathogenic variant…”
BackgroundKhera, A. V., Chaffin, M., Aragam, K. G., Haas, M. E., Roselli, C., Choi, S. H., Natarajan, P., Lander, E. S., Lubitz, S. A., Ellinor, P. T., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0183-z · Cited by 2,953 · cited 1×
“, 2019; Lewis and Vassos, 2020) and potentially used as a tool for the prediction of the overall disease risk in both monogenic and polygenic disorders (Khera et al., 2018).”
MethodAn Expanded View of Complex Traits: From Polygenic to Omnigenic
Boyle, E. A., Li, Y. I., & Pritchard, J. K. (2017) · Cell · doi:10.1016/j.cell.2017.05.038 · Cited by 2,851
Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade
Chiti, F., & Dobson, C. M. (2017) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-061516-045115 · Cited by 2,629 · cited 1×
“Agedependent penetrance of cognitive phenotypes is also seen in diseases caused by the slow accumulation of aberrant proteins, where variation can affect the rate at which the protein accumulates (Chiti and Dobson, 2017).”
BackgroundPredicting effects of noncoding variants with deep learning–based sequence model
Zhou, J., & Troyanskaya, O. G. (2015) · Nature Methods · doi:10.1038/nmeth.3547 · Cited by 2,338
Disruptions of Topological Chromatin Domains Cause Pathogenic Rewiring of Gene-Enhancer Interactions
Lupiáñez, D. G., Kraft, K., Heinrich, V., Krawitz, P., Brancati, F., Klopocki, E., Horn, D., Kayserili, H., Opitz, J. M., Laxova, R., et al. (2015) · Cell · doi:10.1016/j.cell.2015.04.004 · Cited by 2,132 · cited 1×
“Structural changes that affect transcription factor binding can lead to functional gene expression changes (McArthur and Capra, 2021), as seen in the EPHA4 locus, where deletions or duplications that overlap the TAD boundary can cause severe limb malformations (Lupiáñez et al., 2015), while deletion of the entire locu…”
BackgroundBurnside, R. D. (2015) · Cytogenetic and Genome Research · doi:10.1159/000438708 · Cited by 1,946
Meta-Analysis of BRCA1 and BRCA2 Penetrance
Chen, S., & Parmigiani, G. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.1066 · Cited by 1,802 · cited 5×
“Meta-analysis studies have shown that the cumulative breast cancer risks for BRCA1 and BRCA2 pathogenic variant carriers by age 70 are 57–65% and 45–49%, respectively (Antoniou et al., 2003; Chen and Parmigiani, 2007), highlighting the difficulties with predicting the course of disease even in known pathogenic variant…”
BackgroundInfluentialEstimating cumulative point prevalence of rare diseases: analysis of the Orphanet database
Nguengang Wakap, S., Lambert, D. M., Olry, A., Rodwell, C., Gueydan, C., Lanneau, V., Murphy, D., Le Cam, Y., & Rath, A. (2020) · European Journal of Human Genetics · doi:10.1038/s41431-019-0508-0 · Cited by 1,752
Kalia, S. S., Adelman, K., Bale, S. J., Chung, W. K., Eng, C., Evans, J. P., Herman, G. E., Hufnagel, S. B., Klein, T. E., Korf, B. R., et al. (2017) · Genetics in Medicine · doi:10.1038/gim.2016.190 · Cited by 1,644
Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases
Sanna, S., van Zuydam, N. R., Mahajan, A., Kurilshikov, A., Vich Vila, A., Võsa, U., Mujagic, Z., Masclee, A. A. M., Jonkers, D. M. A. E., Oosting, M., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0350-x · Cited by 1,539
The Missing Diversity in Human Genetic Studies
Sirugo, G., Williams, S. M., & Tishkoff, S. A. (2019) · Cell · doi:10.1016/j.cell.2019.02.048 · Cited by 1,516
Advances in epigenetics link genetics to the environment and disease
Cavalli, G., & Heard, E. (2019) · Nature · doi:10.1038/s41586-019-1411-0 · Cited by 1,509 · cited 1×
“Epigenetic factors can provide a mechanistic link between the environment and gene expression (Dolinoy et al., 2007; Cavalli and Heard, 2019; Safi-Stibler and Gabory, 2020), and studies of the human microbiome can also explain some extreme variability in genotype–phenotype presentation (Sanna et al.”
BackgroundAssociation analysis identifies 65 new breast cancer risk loci
Michailidou, K., Lindström, S., Dennis, J., Beesley, J., Hui, S., Kar, S., Lemaçon, A., Soucy, P., Glubb, D., Rostamianfar, A., et al. (2017) · Nature · doi:10.1038/nature24284 · Cited by 1,413
Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy
Marian, A. J., & Braunwald, E. (2017) · Circulation Research · doi:10.1161/circresaha.117.311059 · Cited by 1,403
Polygenic risk scores: from research tools to clinical instruments
Lewis, C. M., & Vassos, E. (2020) · Genome Medicine · doi:10.1186/s13073-020-00742-5 · Cited by 1,360
Stenson, P. D., Mort, M., Ball, E. V., Evans, K., Hayden, M., Heywood, S., Hussain, M., Phillips, A. D., & Cooper, D. N. (2017) · Human Genetics · doi:10.1007/s00439-017-1779-6 · Cited by 1,345
Effective gene expression prediction from sequence by integrating long-range interactions
Avsec, Ž., Agarwal, V., Visentin, D., Ledsam, J. R., Grabska-Barwinska, A., Taylor, K. R., Assael, Y., Jumper, J., Kohli, P., & Kelley, D. R. (2021) · Nature Methods · doi:10.1038/s41592-021-01252-x · Cited by 1,326 · cited 2×
“Improved computational approaches to identify candidate modifier gene interactions across the genome are needed (Lee et al., 2010), as well as identification of functional non-coding regions and the genes that they affect (Petrovski et al., 2015), and machine learning approaches such as DeepSEA and Enformer (Avsec et…”
High-throughput discovery of novel developmental phenotypes
The International Mouse Phenotyping Consortium, Dickinson, M. E., Flenniken, A. M., Ji, X., Teboul, L., Wong, M. D., White, J. K., Meehan, T. F., Weninger, W. J., Westerberg, H., et al. (2016) · Nature · doi:10.1038/nature19356 · Cited by 1,196 · cited 2×
“Phenotypic variability has also been observed in inbred mice with a defined genetic background (Dickinson et al., 2016), as well as in monozygotic (MZ) twins (Baranzini et al.”
BackgroundMicroRNA in Control of Gene Expression: An Overview of Nuclear Functions
Catalanotto, C., Cogoni, C., & Zardo, G. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17101712 · Cited by 1,190
Nagy, E., & Maquat, L. E. (1998) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(98)01208-0 · Cited by 1,187
From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus
Musunuru, K., Strong, A., Frank-Kamenetsky, M., Lee, N. E., Ahfeldt, T., Sachs, K. V., Li, X., Li, H., Kuperwasser, N., Ruda, V. M., et al. (2010) · Nature · doi:10.1038/nature09266 · Cited by 1,140 · cited 1×
“Variants that create novel binding sites for transcription factors have been implicated in affecting penetrance through altering the gene expression, including a common non-coding polymorphism that alters the hepatic expression of SORT1 (Musunuru et al., 2010), contributing to myocardial infarction.”
BackgroundUntranslated regions of mRNAs.
(2002) · Genome biology · doi:10.1186/gb-2002-3-3-reviews0004 · Cited by 987
Hagerman, R. J., Berry-Kravis, E., Hazlett, H. C., Bailey, D. B., Moine, H., Kooy, R. F., Tassone, F., Gantois, I., Sonenberg, N., Mandel, J. L., et al. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.65 · Cited by 838 · cited 3×
“Disease Causal gene Modifier gene/locus Phenotypic effect Cystic fibrosis CFTR TGFB1 (Racanelli et al., 2018) Increased severity of lung disease IFRD1 (Gu et al., 2009) Earlier age of the onset of chronic infection DCTN4 (Emond et al., 2012; Viel et al., 2016) Sickle cell disease HBB BCL11A (Bae et al., 2012) Prolonge…”
BackgroundImproving genetic diagnosis in Mendelian disease with transcriptome sequencing
Cummings, B. B., Marshall, J. L., Tukiainen, T., Lek, M., Donkervoort, S., Foley, A. R., Bolduc, V., Waddell, L. B., Sandaradura, S. A., O’Grady, G. L., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aal5209 · Cited by 831
Genetic compensation: A phenomenon in search of mechanisms
El-Brolosy, M. A., & Stainier, D. Y. R. (2017) · PLOS Genetics · doi:10.1371/journal.pgen.1006780 · Cited by 829
Genetic Misdiagnoses and the Potential for Health Disparities
Manrai, A. K., Funke, B. H., Rehm, H. L., Olesen, M. S., Maron, B. A., Szolovits, P., Margulies, D. M., Loscalzo, J., & Kohane, I. S. (2016) · New England Journal of Medicine · doi:10.1056/nejmsa1507092 · Cited by 808 · cited 1×
“CHALLENGES WITHIN DETERMINING PENETRANCE AND EXPRESSIVITY Incomplete Penetrance Challenges Definitions of Pathogenicity Determining the penetrance and expressivity of a variant can be difficult because it is sensitive to ascertainment context, and many studies are designed to enable the discovery of causative pathogen…”
BackgroundResolution of Disease Phenotypes Resulting from Multilocus Genomic Variation
Posey, J. E., Harel, T., Liu, P., Rosenfeld, J. A., James, R. A., Coban Akdemir, Z. H., Walkiewicz, M., Bi, W., Xiao, R., Ding, Y., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1516767 · Cited by 769
White, M. C., Holman, D. M., Boehm, J. E., Peipins, L. A., Grossman, M., & Jane Henley, S. (2014) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2013.10.029 · Cited by 762
Walsh, R., Thomson, K. L., Ware, J. S., Funke, B. H., Woodley, J., McGuire, K. J., Mazzarotto, F., Blair, E., Seller, A., Taylor, J. C., et al. (2017) · Genetics in Medicine · doi:10.1038/gim.2016.90 · Cited by 734
Lee, A., Mavaddat, N., Wilcox, A. N., Cunningham, A. P., Carver, T., Hartley, S., Babb de Villiers, C., Izquierdo, A., Simard, J., Schmidt, M. K., et al. (2019) · Genetics in Medicine · doi:10.1038/s41436-018-0406-9 · Cited by 721
CNVs conferring risk of autism or schizophrenia affect cognition in controls
Stefansson, H., Meyer-Lindenberg, A., Steinberg, S., Magnusdottir, B., Morgen, K., Arnarsdottir, S., Bjornsdottir, G., Walters, G. B., Jonsdottir, G. A., Doyle, O. M., et al. (2014) · Nature · doi:10.1038/nature12818 · Cited by 699 · cited 1×
“, 2013), albeit with a range of cognitive and neuropsychiatric difficulties despite none of them reaching traditional clinical diagnosis threshold levels (Stefansson et al., 2014).”
BackgroundA brief history of human disease genetics
Claussnitzer, M., Cho, J. H., Collins, R., Cox, N. J., Dermitzakis, E. T., Hurles, M. E., Kathiresan, S., Kenny, E. E., Lindgren, C. M., MacArthur, D. G., et al. (2020) · Nature · doi:10.1038/s41586-019-1879-7 · Cited by 697 · cited 1×
“The study of genetic disease has often been divided into rare monogenic forms of disease and more common polygenic complex disorders (Claussnitzer et al., 2020).”
BackgroundVariant interpretation using population databases: Lessons from gnomAD
Gudmundsson, S., Singer‐Berk, M., Watts, N. A., Phu, W., Goodrich, J. K., Solomonson, M., Genome Aggregation Database Consortium, Rehm, H. L., MacArthur, D. G., & O'Donnell‐Luria, A. (2022) · Human Mutation · doi:10.1002/humu.24309 · Cited by 674
Formation of new chromatin domains determines pathogenicity of genomic duplications
Franke, M., Ibrahim, D. M., Andrey, G., Schwarzer, W., Heinrich, V., Schöpflin, R., Kraft, K., Kempfer, R., Jerković, I., Chan, W.-L., et al. (2016) · Nature · doi:10.1038/nature19800 · Cited by 673
The Polygenic and Monogenic Basis of Blood Traits and Diseases
Vuckovic, D., Bao, E. L., Akbari, P., Lareau, C. A., Mousas, A., Jiang, T., Chen, M.-H., Raffield, L. M., Tardaguila, M., Huffman, J. E., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.008 · Cited by 671
The impact of sex on gene expression across human tissues
Oliva, M., Muñoz-Aguirre, M., Kim-Hellmuth, S., Wucher, V., Gewirtz, A. D. H., Cotter, D. J., Parsana, P., Kasela, S., Balliu, B., Viñuela, A., et al. (2020) · Science · doi:10.1126/science.aba3066 · Cited by 670
A recurrent 16p12.1 microdeletion supports a two-hit model for severe developmental delay
Girirajan, S., Rosenfeld, J. A., Cooper, G. M., Antonacci, F., Siswara, P., Itsara, A., Vives, L., Walsh, T., McCarthy, S. E., Baker, C., et al. (2010) · Nature Genetics · doi:10.1038/ng.534 · Cited by 667 · cited 5×
“, 2021) supporting a “two-hit” model of NDDs (Girirajan et al., 2010).”
BackgroundInfluentialCooper, D. N., Krawczak, M., Polychronakos, C., Tyler-Smith, C., & Kehrer-Sawatzki, H. (2013) · Human Genetics · doi:10.1007/s00439-013-1331-2 · Cited by 645
The Genetic Basis of Mendelian Phenotypes: Discoveries, Challenges, and Opportunities
Chong, J. X., Buckingham, K. J., Jhangiani, S. N., Boehm, C., Sobreira, N., Smith, J. D., Harrell, T. M., McMillin, M. J., Wiszniewski, W., Gambin, T., et al. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.06.009 · Cited by 643
A genomic view of mosaicism and human disease
Biesecker, L. G., & Spinner, N. B. (2013) · Nature Reviews Genetics · doi:10.1038/nrg3424 · Cited by 619
Paediatric genomics: diagnosing rare disease in children
Wright, C. F., FitzPatrick, D. R., & Firth, H. V. (2018) · Nature Reviews Genetics · doi:10.1038/nrg.2017.116 · Cited by 618
Self-citationGenome-wide association studies establish that human intelligence is highly heritable and polygenic
Davies, G., Tenesa, A., Payton, A., Yang, J., Harris, S. E., Liewald, D., Ke, X., Le Hellard, S., Christoforou, A., Luciano, M., et al. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.85 · Cited by 608
Jacquemont, S., Coe, B. P., Hersch, M., Duyzend, M. H., Krumm, N., Bergmann, S., Beckmann, J. S., Rosenfeld, J. A., & Eichler, E. E. (2014) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2014.02.001 · Cited by 605
Epigenetics: The Science of Change
Weinhold, B. (2006) · Environmental Health Perspectives · doi:10.1289/ehp.114-a160 · Cited by 574
How many rare diseases are there?
Haendel, M., Vasilevsky, N., Unni, D., Bologa, C., Harris, N., Rehm, H., Hamosh, A., Baynam, G., Groza, T., McMurry, J., et al. (2020) · Nature Reviews Drug Discovery · doi:10.1038/d41573-019-00180-y · Cited by 554 · cited 1×
“, 2020) of all rare diseases are genetic in origin, andmost of these are thought to bemonogenic in nature (Haendel et al., 2020).”
BackgroundAutophagy and inflammation in chronic respiratory disease
Racanelli, A. C., Kikkers, S. A., Choi, A. M. K., & Cloonan, S. M. (2018) · Autophagy · doi:10.1080/15548627.2017.1389823 · Cited by 547
The rules and impact of nonsense-mediated mRNA decay in human cancers
Lindeboom, R. G. H., Supek, F., & Lehner, B. (2016) · Nature Genetics · doi:10.1038/ng.3664 · Cited by 545
Discovery of common and rare genetic risk variants for colorectal cancer
Huyghe, J. R., Bien, S. A., Harrison, T. A., Kang, H. M., Chen, S., Schmit, S. L., Conti, D. V., Qu, C., Jeon, J., Edlund, C. K., et al. (2019) · Nature Genetics · doi:10.1038/s41588-018-0286-6 · Cited by 544
Epigenetic gene regulation: Linking early developmental environment to adult disease
Dolinoy, D. C., Weidman, J. R., & Jirtle, R. L. (2007) · Reproductive Toxicology · doi:10.1016/j.reprotox.2006.08.012 · Cited by 498
Plastin 3 Is a Protective Modifier of Autosomal Recessive Spinal Muscular Atrophy
Oprea, G. E., Kröber, S., McWhorter, M. L., Rossoll, W., Müller, S., Krawczak, M., Bassell, G. J., Beattie, C. E., & Wirth, B. (2008) · Science · doi:10.1126/science.1155085 · Cited by 497
Calucho, M., Bernal, S., Alías, L., March, F., Venceslá, A., Rodríguez-Álvarez, F. J., Aller, E., Fernández, R. M., Borrego, S., Millán, J. M., et al. (2018) · Neuromuscular Disorders · doi:10.1016/j.nmd.2018.01.003 · Cited by 497
Ittisoponpisan, S., Islam, S. A., Khanna, T., Alhuzimi, E., David, A., & Sternberg, M. J. E. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.04.009 · Cited by 489
Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis
Baranzini, S. E., Mudge, J., van Velkinburgh, J. C., Khankhanian, P., Khrebtukova, I., Miller, N. A., Zhang, L., Farmer, A. D., Bell, C. J., Kim, R. W., et al. (2010) · Nature · doi:10.1038/nature08990 · Cited by 476
Polygenic background modifies penetrance of monogenic variants for tier 1 genomic conditions
Fahed, A. C., Wang, M., Homburger, J. R., Patel, A. P., Bick, A. G., Neben, C. L., Lai, C., Brockman, D., Philippakis, A., Ellinor, P. T., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17374-3 · Cited by 455
The health consequences of smoking: Cancer
Newcomb, P. A., & Carbone, P. P. (1992) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30355-8 · Cited by 449
International Cooperation to Enable the Diagnosis of All Rare Genetic Diseases
Boycott, K. M., Rath, A., Chong, J. X., Hartley, T., Alkuraya, F. S., Baynam, G., Brookes, A. J., Brudno, M., Carracedo, A., den Dunnen, J. T., et al. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.04.003 · Cited by 447
Quantifying prion disease penetrance using large population control cohorts
Minikel, E. V., Vallabh, S. M., Lek, M., Estrada, K., Samocha, K. E., Sathirapongsasuti, J. F., McLean, C. Y., Tung, J. Y., Yu, L. P. C., Gambetti, P., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad5169 · Cited by 442
miR-182-Mediated Downregulation of BRCA1 Impacts DNA Repair and Sensitivity to PARP Inhibitors
Moskwa, P., Buffa, F. M., Pan, Y., Panchakshari, R., Gottipati, P., Muschel, R. J., Beech, J., Kulshrestha, R., Abdelmohsen, K., Weinstock, D. M., et al. (2011) · Molecular Cell · doi:10.1016/j.molcel.2010.12.005 · Cited by 430
Molecular mechanism for distinct neurological phenotypes conveyed by allelic truncating mutations
Inoue, K., Khajavi, M., Ohyama, T., Hirabayashi, S.-I., Wilson, J., Reggin, J. D., Mancias, P., Butler, I. J., Wilkinson, M. F., Wegner, M., et al. (2004) · Nature Genetics · doi:10.1038/ng1322 · Cited by 429
Estimates of penetrance for recurrent pathogenic copy-number variations
Rosenfeld, J. A., Coe, B. P., Eichler, E. E., Cuckle, H., & Shaffer, L. G. (2013) · Genetics in Medicine · doi:10.1038/gim.2012.164 · Cited by 425
(2018) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-63233-3.00009-9 · Cited by 421
Nonsense-mediated mRNA decay modulates clinical outcome of genetic disease
Khajavi, M., Inoue, K., & Lupski, J. R. (2006) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201649 · Cited by 417
mRNA localization: message on the move
Jansen, R.-P. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35067016 · Cited by 413
Detecting epistasis in human complex traits
Wei, W.-H., Hemani, G., & Haley, C. S. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3747 · Cited by 411
Hosseini, S. M., Kim, R., Udupa, S., Costain, G., Jobling, R., Liston, E., Jamal, S. M., Szybowska, M., Morel, C. F., Bowdin, S., et al. (2018) · Circulation · doi:10.1161/circulationaha.118.035070 · Cited by 371
Harper, A. R., Goel, A., Grace, C., Thomson, K. L., Petersen, S. E., Xu, X., Waring, A., Ormondroyd, E., Kramer, C. M., Ho, C. Y., et al. (2021) · Nature Genetics · doi:10.1038/s41588-020-00764-0 · Cited by 353
What about the girls? Sex-based differences in autistic traits and adaptive skills
Ratto, A. B., Kenworthy, L., Yerys, B. E., Bascom, J., Wieckowski, A. T., White, S. W., Wallace, G. L., Pugliese, C., Schultz, R. T., Ollendick, T. H., et al. (2018) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-017-3413-9 · Cited by 342
Common genetic variants contribute to risk of rare severe neurodevelopmental disorders
Niemi, M. E. K., Martin, H. C., Rice, D. L., Gallone, G., Gordon, S., Kelemen, M., McAloney, K., McRae, J., Radford, E. J., Yu, S., et al. (2018) · Nature · doi:10.1038/s41586-018-0566-4 · Cited by 340 · cited 1×
“, 2021) and common variants that affect the severity of monogenic disease (Niemi et al., 2018; Goodrich et al., 2021).”
BackgroundSelf-citationMolecular Mechanisms of Disease-Causing Missense Mutations
Stefl, S., Nishi, H., Petukh, M., Panchenko, A. R., & Alexov, E. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.07.014 · Cited by 336
Kuchenbaecker, K. B., McGuffog, L., Barrowdale, D., Lee, A., Soucy, P., Dennis, J., Domchek, S. M., Robson, M., Spurdle, A. B., Ramus, S. J., et al. (2017) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djw302 · Cited by 327
Family history and risk of breast cancer: an analysis accounting for family structure
Brewer, H. R., Jones, M. E., Schoemaker, M. J., Ashworth, A., & Swerdlow, A. J. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-017-4325-2 · Cited by 316
Genetic modifiers of sickle cell disease
Steinberg, M. H., & Sebastiani, P. (2012) · American Journal of Hematology · doi:10.1002/ajh.23232 · Cited by 315
Analysis of 589,306 genomes identifies individuals resilient to severe Mendelian childhood diseases
Chen, R., Shi, L., Hakenberg, J., Naughton, B., Sklar, P., Zhang, J., Zhou, H., Tian, L., Prakash, O., Lemire, M., et al. (2016) · Nature Biotechnology · doi:10.1038/nbt.3514 · Cited by 310 · cited 2×
“, 2017); however, even within healthy population cohorts there have been individuals identified with the associated phenotype but who have previously been described as unaffected (Chen et al., 2016), as well as individuals who display symptoms but are below the clinical threshold for classification.”
BackgroundRecessive mutations in a distal PTF1A enhancer cause isolated pancreatic agenesis
International Pancreatic Agenesis Consortium, Weedon, M. N., Cebola, I., Patch, A.-M., Flanagan, S. E., De Franco, E., Caswell, R., Rodríguez-Seguí, S. A., Shaw-Smith, C., Cho, C. H.-H., et al. (2014) · Nature Genetics · doi:10.1038/ng.2826 · Cited by 297
Genetic Variation in an Individual Human Exome
Ng, P. C., Levy, S., Huang, J., Stockwell, T. B., Walenz, B. P., Li, K., Axelrod, N., Busam, D. A., Strausberg, R. L., & Venter, J. C. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000160 · Cited by 291
Hanson, E., Bernier, R., Porche, K., Jackson, F. I., Goin-Kochel, R. P., Snyder, L. G., Snow, A. V., Wallace, A. S., Campe, K. L., Zhang, Y., et al. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.04.021 · Cited by 277
De novo loss- or gain-of-function mutations in KCNA2 cause epileptic encephalopathy
EuroEPINOMICS, R. E. S., Syrbe, S., Hedrich, U. B. S., Riesch, E., Djémié, T., Müller, S., Møller, R. S., Maher, B., Hernandez-Hernandez, L., Synofzik, M., et al. (2015) · Nature Genetics · doi:10.1038/ng.3239 · Cited by 276
Xue, Y., Chen, Y., Ayub, Q., Huang, N., Ball, E. V., Mort, M., Phillips, A. D., Shaw, K., Stenson, P. D., Cooper, D. N., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.10.015 · Cited by 274
Parental Somatic Mosaicism Is Underrecognized and Influences Recurrence Risk of Genomic Disorders
Campbell, I. M., Yuan, B., Robberecht, C., Pfundt, R., Szafranski, P., McEntagart, M. E., Nagamani, S. C. S., Erez, A., Bartnik, M., Wiśniowiecka-Kowalnik, B., et al. (2014) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2014.07.003 · Cited by 274
NOS1AP Is a Genetic Modifier of the Long-QT Syndrome
Crotti, L., Monti, M. C., Insolia, R., Peljto, A., Goosen, A., Brink, P. A., Greenberg, D. A., Schwartz, P. J., & George, A. L. (2009) · Circulation · doi:10.1161/circulationaha.109.879643 · Cited by 274
A common allele in RPGRIP1L is a modifier of retinal degeneration in ciliopathies
Khanna, H., Davis, E. E., Murga-Zamalloa, C. A., Estrada-Cuzcano, A., Lopez, I., den Hollander, A. I., Zonneveld, M. N., Othman, M. I., Waseem, N., Chakarova, C. F., et al. (2009) · Nature Genetics · doi:10.1038/ng.366 · Cited by 272
Helmbacher, F., Schneider-Maunoury, S., Topilko, P., Tiret, L., & Charnay, P. (2000) · Development · doi:10.1242/dev.127.15.3313 · Cited by 262
Recommendations for clinical interpretation of variants found in non-coding regions of the genome
Ellingford, J. M., Ahn, J. W., Bagnall, R. D., Baralle, D., Barton, S., Campbell, C., Downes, K., Ellard, S., Duff-Farrier, C., FitzPatrick, D. R., et al. (2022) · Genome Medicine · doi:10.1186/s13073-022-01073-3 · Cited by 259
Self-citationPlatzer, K., Yuan, H., Schütz, H., Winschel, A., Chen, W., Hu, C., Kusumoto, H., Heyne, H. O., Helbig, K. L., Tang, S., et al. (2017) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2016-104509 · Cited by 252
Disease-Associated Short Tandem Repeats Co-localize with Chromatin Domain Boundaries
Sun, J. H., Zhou, L., Emerson, D. J., Phyo, S. A., Titus, K. R., Gong, W., Gilgenast, T. G., Beagan, J. A., Davidson, B. L., Tassone, F., et al. (2018) · Cell · doi:10.1016/j.cell.2018.08.005 · Cited by 249 · cited 1×
“Non-coding variants within enhancer regions can be a cause of phenotypic diversity through alterations in gene expression, therefore affecting overall disease phenotype presentation (Sun et al., 2018).”
BackgroundPost-zygotic Point Mutations Are an Underrecognized Source of De Novo Genomic Variation
Acuna-Hidalgo, R., Bo, T., Kwint, M. P., van de Vorst, M., Pinelli, M., Veltman, J. A., Hoischen, A., Vissers, L. E. L. M., & Gilissen, C. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.05.008 · Cited by 246
Mapping the energetic and allosteric landscapes of protein binding domains
Faure, A. J., Domingo, J., Schmiedel, J. M., Hidalgo-Carcedo, C., Diss, G., & Lehner, B. (2022) · Nature · doi:10.1038/s41586-022-04586-4 · Cited by 246
To NMD or Not To NMD: Nonsense-Mediated mRNA Decay in Cancer and Other Genetic Diseases
Supek, F., Lehner, B., & Lindeboom, R. G. H. (2021) · Trends in Genetics · doi:10.1016/j.tig.2020.11.002 · Cited by 244
Emison, E. S., Garcia-Barcelo, M., Grice, E. A., Lantieri, F., Amiel, J., Burzynski, G., Fernandez, R. M., Hao, L., Kashuk, C., West, K., et al. (2010) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2010.06.007 · Cited by 243
Social and demographic factors that influence the diagnosis of autistic spectrum disorders
Russell, G., Steer, C., & Golding, J. (2011) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-010-0294-z · Cited by 239
Phenylalanine hydroxylase: Function, structure, and regulation
Flydal, M. I., & Martinez, A. (2013) · IUBMB Life · doi:10.1002/iub.1150 · Cited by 232
Nonsense-mediated decay in genetic disease: Friend or foe?
Miller, J. N., & Pearce, D. A. (2014) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2014.05.001 · Cited by 227
Tumor suppressor BRCA1 epigenetically controls oncogenic microRNA-155
Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab), Chang, S., Wang, R.-H., Akagi, K., Kim, K.-A., Martin, B. K., Cavallone, L., Haines, D. C., Basik, M., Mai, P., et al. (2011) · Nature Medicine · doi:10.1038/nm.2459 · Cited by 224
National Heart, L., Emond, M. J., Lung, G. O., Louie, T., Emerson, J., Zhao, W., Mathias, R. A., Knowles, M. R., Wright, F. A., Rieder, M. J., et al. (2012) · Nature Genetics · doi:10.1038/ng.2344 · Cited by 223
Identification of a large set of rare complete human knockouts
Sulem, P., Helgason, H., Oddson, A., Stefansson, H., Gudjonsson, S. A., Zink, F., Hjartarson, E., Sigurdsson, G. T., Jonasdottir, A., Jonasdottir, A., et al. (2015) · Nature Genetics · doi:10.1038/ng.3243 · Cited by 220 · cited 1×
“The functional redundancy of genes and rewiring of affected genetic networks may affect the penetrance and expressivity of corresponding phenotypes, and the consequence of a pathogenic variant may be influenced by variation across the genome (Payne and Wagner, 2015) and explain why certain LoF variants are tolerated b…”
BackgroundGRIN2A -related disorders: genotype and functional consequence predict phenotype
Strehlow, V., Heyne, H. O., Vlaskamp, D. R. M., Marwick, K. F. M., Rudolf, G., de Bellescize, J., Biskup, S., Brilstra, E. H., Brouwer, O. F., Callenbach, P. M. C., et al. (2019) · Brain · doi:10.1093/brain/awy304 · Cited by 220
Coban-Akdemir, Z., White, J. J., Song, X., Jhangiani, S. N., Fatih, J. M., Gambin, T., Bayram, Y., Chinn, I. K., Karaca, E., Punetha, J., et al. (2018) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2018.06.009 · Cited by 219
Modified penetrance of coding variants by cis-regulatory variation contributes to disease risk
Castel, S. E., Cervera, A., Mohammadi, P., Aguet, F., Reverter, F., Wolman, A., Guigo, R., Iossifov, I., Vasileva, A., & Lappalainen, T. (2018) · Nature Genetics · doi:10.1038/s41588-018-0192-y · Cited by 217
Chromatin three-dimensional interactions mediate genetic effects on gene expression
Delaneau, O., Zazhytska, M., Borel, C., Giannuzzi, G., Rey, G., Howald, C., Kumar, S., Ongen, H., Popadin, K., Marbach, D., et al. (2019) · Science · doi:10.1126/science.aat8266 · Cited by 217
Wright, C. F., West, B., Tuke, M., Jones, S. E., Patel, K., Laver, T. W., Beaumont, R. N., Tyrrell, J., Wood, A. R., Frayling, T. M., et al. (2019) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2018.12.015 · Cited by 212
Self-citationvan Karnebeek, C. D. M., & Stockler, S. (2012) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2011.11.191 · Cited by 212
Epigenetics of discordant monozygotic twins: implications for disease
Castillo-Fernandez, J. E., Spector, T. D., & Bell, J. T. (2014) · Genome Medicine · doi:10.1186/s13073-014-0060-z · Cited by 208
Johnston, J. J., Rubinstein, W. S., Facio, F. M., Ng, D., Singh, L. N., Teer, J. K., Mullikin, J. C., & Biesecker, L. G. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.05.021 · Cited by 206
Whole-genome sequencing of a healthy aging cohort
Erikson, G. A., Bodian, D. L., Rueda, M., Molparia, B., Scott, E. R., Scott-Van Zeeland, A. A., Topol, S. E., Wineinger, N. E., Niederhuber, J. E., Topol, E. J., et al. (2016) · Cell · doi:10.1016/j.cell.2016.03.022 · Cited by 202
Genetic variants in mRNA untranslated regions
Steri, M., Idda, M. L., Whalen, M. B., & Orrù, V. (2018) · WIREs RNA · doi:10.1002/wrna.1474 · Cited by 202
McArthur, E., & Capra, J. A. (2021) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2021.01.001 · Cited by 202
Scott, F. J., Baron-Cohen, S., Bolton, P., & Brayne, C. (2002) · Autism · doi:10.1177/1362361302006003002 · Cited by 199
Pilling, L. C., Tamosauskaite, J., Jones, G., Wood, A. R., Jones, L., Kuo, C.-L., Kuchel, G. A., Ferrucci, L., & Melzer, D. (2019) · BMJ · doi:10.1136/bmj.k5222 · Cited by 198
The BabySeq project: implementing genomic sequencing in newborns
The BabySeq Project Team, Holm, I. A., Agrawal, P. B., Ceyhan-Birsoy, O., Christensen, K. D., Fayer, S., Frankel, L. A., Genetti, C. A., Krier, J. B., LaMay, R. C., et al. (2018) · BMC Pediatrics · doi:10.1186/s12887-018-1200-1 · Cited by 195
Pizzo, L., Jensen, M., Polyak, A., Rosenfeld, J. A., Mannik, K., Krishnan, A., McCready, E., Pichon, O., Le Caignec, C., Van Dijck, A., et al. (2019) · Genetics in Medicine · doi:10.1038/s41436-018-0266-3 · Cited by 193 · cited 3×
“It has been shown that children with monogenic NDDs have an excess of other damaging genetic variants compared to their either mildly clinically affected or asymptomatic carrier parents, with the extra genetic burden being enriched in genes that are highly expressed within the brain and in neurodevelopmental pathways…”
BackgroundFLCN : The causative gene for Birt-Hogg-Dubé syndrome
Schmidt, L. S., & Linehan, W. M. (2018) · Gene · doi:10.1016/j.gene.2017.09.044 · Cited by 191
Chromothriptic Cure of WHIM Syndrome
McDermott, D. H., Gao, J.-L., Liu, Q., Siwicki, M., Martens, C., Jacobs, P., Velez, D., Yim, E., Bryke, C. R., Hsu, N., et al. (2015) · Cell · doi:10.1016/j.cell.2015.01.014 · Cited by 190
van der Kolk, D. M., de Bock, G. H., Leegte, B. K., Schaapveld, M., Mourits, M. J. E., de Vries, J., van der Hout, A. H., & Oosterwijk, J. C. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0805-3 · Cited by 187
Phenylketonuria: a review of current and future treatments.
Hafid, N. A., & Christodoulou, J. (2015) · PubMed · doi:10.3978/j.issn.2224-4336.2015.10.07 · Cited by 185
Transcript expression-aware annotation improves rare variant interpretation
Cummings, B. B., Karczewski, K. J., Kosmicki, J. A., Seaby, E. G., Watts, N. A., Singer-Berk, M., Mudge, J. M., Karjalainen, J., Satterstrom, F. K., O’Donnell-Luria, A. H., et al. (2020) · Nature · doi:10.1038/s41586-020-2329-2 · Cited by 180
Hart, R., Biesecker, B. B., Zawatsky, C. L. B., Christensen, K. D., Amendola, L. M., Bergstrom, K. L., Biswas, S., Bowling, K. M., Brothers, K. B., Conlin, L. K., et al. (2018) · Genetics in Medicine · doi:10.1038/s41436-018-0308-x · Cited by 179
Characterising the loss-of-function impact of 5’ untranslated region variants in 15,708 individuals
Whiffin, N., Karczewski, K. J., Zhang, X., Chothani, S., Smith, M. J., Evans, D. G., Roberts, A. M., Quaife, N. M., Schafer, S., Rackham, O., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-10717-9 · Cited by 179
Lu, L., Liu, X., Huang, W.-K., Giusti-Rodríguez, P., Cui, J., Zhang, S., Xu, W., Wen, Z., Ma, S., Rosen, J. D., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.06.007 · Cited by 179
Intellectual abilities in a large sample of children with Velo–Cardio–Facial Syndrome: an update
De Smedt, B., Devriendt, K., Fryns, J. ‐., Vogels, A., Gewillig, M., & Swillen, A. (2007) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.2007.00955.x · Cited by 178
Wallace, D. R., Taalab, Y. M., Heinze, S., Lovaković, B. T., Pizent, A., Renieri, E. A., Tsatsakis, A. M., Farooqi, A. A., Javorac, D., Anđelković, M., et al. (2020) · Cells · doi:10.3390/cells9040901 · Cited by 172
Potassium Channel Gain of Function in Epilepsy: An Unresolved Paradox
Niday, Z., & Tzingounis, A. V. (2018) · The Neuroscientist · doi:10.1177/1073858418763752 · Cited by 171
miR-9 Regulation of BRCA1 and Ovarian Cancer Sensitivity to Cisplatin and PARP Inhibition
Sun, C., Li, N., Yang, Z., Zhou, B., He, Y., Weng, D., Fang, Y., Wu, P., Chen, P., Yang, X., et al. (2013) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djt302 · Cited by 169
Nonsense-mediated mRNA decay: Inter-individual variability and human disease
Nguyen, L. S., Wilkinson, M., & Gécz, J. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.10.016 · Cited by 168
Genetic Modifiers and Rare Mendelian Disease
Rahit, K. M. T. H., & Tarailo-Graovac, M. (2020) · Genes · doi:10.3390/genes11030239 · Cited by 167
Lareau, L. F., & Brenner, S. E. (2015) · Molecular Biology and Evolution · doi:10.1093/molbev/msv002 · Cited by 166
Proteus syndrome review: molecular, clinical, and pathologic features
Cohen, M. M. (2013) · Clinical Genetics · doi:10.1111/cge.12266 · Cited by 165
MSH3 modifies somatic instability and disease severity in Huntington’s and myotonic dystrophy type 1
Flower, M., Lomeikaite, V., Ciosi, M., Cumming, S., Morales, F., Lo, K., Hensman Moss, D., Jones, L., Holmans, P., Monckton, D. G., et al. (2019) · Brain · doi:10.1093/brain/awz115 · Cited by 165
Clinical spectrum and genotype–phenotype associations of KCNA2-related encephalopathies
Masnada, S., Hedrich, U. B. S., Gardella, E., Schubert, J., Kaiwar, C., Klee, E. W., Lanpher, B. C., Gavrilova, R. H., Synofzik, M., Bast, T., et al. (2017) · Brain · doi:10.1093/brain/awx184 · Cited by 164 · cited 1×
“, 2019); similarly, GoF variants in highly conserved regions of the potassium channel of KCNA2 were associated with more severe epileptic encephalopathy than variants located elsewhere (Masnada et al., 2017).”
BackgroundNguyen, L. S., Kim, H.-G., Rosenfeld, J. A., Shen, Y., Gusella, J. F., Lacassie, Y., Layman, L. C., Shaffer, L. G., & Gécz, J. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt035 · Cited by 164
Recent advances in Lynch syndrome
Biller, L. H., Syngal, S., & Yurgelun, M. B. B. (2019) · Familial Cancer · doi:10.1007/s10689-018-00117-1 · Cited by 164
Safi-Stibler, S., & Gabory, A. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.09.008 · Cited by 164
Reverse mosaicism in Fanconi anemia: natural gene therapy via molecular self-correction
Gross, M., Hanenberg, H., Lobitz, S., Friedl, R., Herterich, S., Dietrich, R., Gruhn, B., Schindler, D., & Hoehn, H. (2002) · Cytogenetic and Genome Research · doi:10.1159/000069805 · Cited by 161
Genetic variants in microRNA genes: impact on microRNA expression, function, and disease
Cammaerts, S., Stražišar, M., Rijk, P. D., & Del‐Favero, J. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00186 · Cited by 159
FLGmutations in ichthyosis vulgaris and atopic eczema: spectrum of mutations and population genetics
Akiyama, M. (2009) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2009.09582.x · Cited by 158
Diverse Epigenetic Mechanisms of Human Disease
Brookes, E., & Shi, Y. (2014) · Annual Review of Genetics · doi:10.1146/annurev-genet-120213-092518 · Cited by 158
Twin pairs showing discordance of phenotype in adult Gaucher's disease
Lachmann, R., Grant, I. R., Halsall, D. J., & Cox, T. M. (2004) · QJM · doi:10.1093/qjmed/hch036 · Cited by 155
Natural Variation in Gene Expression Modulates the Severity of Mutant Phenotypes
Vu, V., Verster, A. J., Schertzberg, M. R., Chuluunbaatar, T., Spensley, M., Pajkic, D., Hart, T., Moffat, J., & Fraser, A. G. (2015) · Cell · doi:10.1016/j.cell.2015.06.037 · Cited by 151
The Intolerance of Regulatory Sequence to Genetic Variation Predicts Gene Dosage Sensitivity
Petrovski, S., Gussow, A. B., Wang, Q., Halvorsen, M., Han, Y., Weir, W. H., Allen, A. S., & Goldstein, D. B. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005492 · Cited by 146
Amin, A. S., Giudicessi, J. R., Tijsen, A. J., Spanjaart, A. M., Reckman, Y. J., Klemens, C. A., Tanck, M. W. T., Kapplinger, J. D., Hofman, N., Sinner, M. F., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr473 · Cited by 145
Mosaic Turner syndrome shows reduced penetrance in an adult population study
Tuke, M. A., Ruth, K. S., Wood, A. R., Beaumont, R. N., Tyrrell, J., Jones, S. E., Yaghootkar, H., Turner, C. L. S., Donohoe, M. E., Brooke, A. M., et al. (2019) · Genetics in Medicine · doi:10.1038/s41436-018-0271-6 · Cited by 144
Long mutant dystrophins and variable phenotypes: evasion of nonsense-mediated decay?
Kerr, T. P., Sewry, C. A., Robb, S. A., & Roberts, R. G. (2001) · Human Genetics · doi:10.1007/s004390100598 · Cited by 142
Dyle, M. C., Kolakada, D., Cortázar, M. A., & Jagannathan, S. (2019) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1560 · Cited by 141
International 22q11.2 Brain and Behavior Consortium, Davies, R. W., Fiksinski, A. M., Breetvelt, E. J., Williams, N. M., Hooper, S. R., Monfeuga, T., Bassett, A. S., Owen, M. J., Gur, R. E., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1103-1 · Cited by 139
Identification of IFRD1 as a modifier gene for cystic fibrosis lung disease
Gu, Y., Harley, I. T. W., Henderson, L. B., Aronow, B. J., Vietor, I., Huber, L. A., Harley, J. B., Kilpatrick, J. R., Langefeld, C. D., Williams, A. H., et al. (2009) · Nature · doi:10.1038/nature07811 · Cited by 138
Developmentally regulated Shh expression is robust to TAD perturbations
Williamson, I., Kane, L., Devenney, P. S., Flyamer, I. M., Anderson, E., Kilanowski, F., Hill, R. E., Bickmore, W. A., & Lettice, L. A. (2019) · Development · doi:10.1242/dev.179523 · Cited by 138
Gallagher, S., Hughes, E., Wagner, S., Tshiaba, P., Rosenthal, E., Roa, B. B., Kurian, A. W., Domchek, S. M., Garber, J., Lancaster, J., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.8501 · Cited by 137
Moreno-De-Luca, A., Evans, D. W., Boomer, K. B., Hanson, E., Bernier, R., Goin-Kochel, R. P., Myers, S. M., Challman, T. D., Moreno-De-Luca, D., Slane, M. M., et al. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.2147 · Cited by 137 · cited 1×
“2 deletions present with variable phenotypic diversities (Moreno-De-Luca et al., 2015; Fetit et al., 2020) and are frequently present in “healthy” general population cohorts (Rosenfeld et al.”
BackgroundRegulation of nonsense‐mediated mRNA decay
Huang, L., & Wilkinson, M. (2012) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1137 · Cited by 137
Flannick, J., Beer, N. L., Bick, A. G., Agarwala, V., Molnes, J., Gupta, N., Burtt, N. P., Florez, J. C., Meigs, J. B., Taylor, H., et al. (2013) · Nature Genetics · doi:10.1038/ng.2794 · Cited by 136
Collaco, J. M., Blackman, S. M., McGready, J., Naughton, K., & Cutting, G. R. (2010) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2010.05.018 · Cited by 136
Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS): Pathophysiology and Clinical Implications
Cabal-Herrera, A. M., Tassanakijpanich, N., Salcedo‐Arellano, M. J., & Hagerman, R. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124391 · Cited by 134
Lee, J., Meyerhardt, J. A., Giovannucci, E. L., & Jeon, J. Y. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120706 · Cited by 133
Severe childhood speech disorder: Gene discovery highlights transcriptional dysregulation
Hildebrand, M. S., Jackson, V. E., Scerri, T. S., van Reyk, O., Coleman, M., Braden, R. O., Turner, S. J., Rigbye, K. A., Boys, A., Barton, S., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000009441 · Cited by 133
Nguyen, L. S., Jolly, L. A., Shoubridge, C., Chan, W.-K., Huang, L., Laumonnier, F., Raynaud, M., Hackett, A., Field, M. J., Rodriguez, J. D., et al. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.163 · Cited by 132
Frequency of genomic secondary findings among 21,915 eMERGE network participants
Gordon, A. S., Zouk, H., Venner, E., Eng, C. M., Funke, B., Amendola, L. M., Carrell, D., Chisholm, R. L., Chung, W. K., Denny, J. C., et al. (2020) · Genetics in Medicine · doi:10.1038/s41436-020-0810-9 · Cited by 130
Høie, M. H., Cagiada, M., Frederiksen, A. H. B., Stein, A., & Lindorff‐Larsen, K. (2022) · Cell Reports · doi:10.1016/j.celrep.2021.110207 · Cited by 130
An assessment of sex bias in neurodevelopmental disorders
Polyak, A., Rosenfeld, J. A., & Girirajan, S. (2015) · Genome Medicine · doi:10.1186/s13073-015-0216-5 · Cited by 129
Quantifying the polygenic contribution to variable expressivity in eleven rare genetic disorders
Oetjens, M. T., Kelly, M., Sturm, A. C., Martin, C. L., & Ledbetter, D. H. (2019) · Nature Communications · doi:10.1038/s41467-019-12869-0 · Cited by 128
Update on gene modifiers in cystic fibrosis
Collaco, J. M., & Cutting, G. R. (2008) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e3283121cdc · Cited by 127
Arrhythmogenesis in Timothy Syndrome is associated with defects in Ca2+-dependent inactivation
Dick, I. E., Joshi‐Mukherjee, R., Yang, W., & Yue, D. T. (2016) · Nature Communications · doi:10.1038/ncomms10370 · Cited by 127
Wu, S., Cho, E., Li, W., Weinstock, M. A., Han, J., & Qureshi, A. A. (2016) · American Journal of Epidemiology · doi:10.1093/aje/kwv282 · Cited by 126
Connecting the CNTNAP2 Networks with Neurodevelopmental Disorders
Poot, M. (2015) · Molecular Syndromology · doi:10.1159/000371594 · Cited by 125
Random monoallelic expression: regulating gene expression one allele at a time
Eckersley-Maslin, M. A., & Spector, D. L. (2014) · Trends in Genetics · doi:10.1016/j.tig.2014.03.003 · Cited by 125
Is ‘likely pathogenic’ really 90% likely? Reclassification data in ClinVar
Harrison, S. M., & Rehm, H. L. (2019) · Genome Medicine · doi:10.1186/s13073-019-0688-9 · Cited by 125
de Marvao, A., McGurk, K. A., Zheng, S. L., Thanaj, M., Bai, W., Duan, J., Biffi, C., Mazzarotto, F., Statton, B., Dawes, T. J. W., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.07.017 · Cited by 124
Walsh, R., Mazzarotto, F., Whiffin, N., Buchan, R., Midwinter, W., Wilk, A., Li, N., Felkin, L., Ingold, N., Govind, R., et al. (2019) · Genome Medicine · doi:10.1186/s13073-019-0616-z · Cited by 121
SCN1A Mutation—Beyond Dravet Syndrome: A Systematic Review and Narrative Synthesis
Ding, J., Li, X., Tian, H., Wang, L., Guo, B., Wang, Y., Li, W., Wang, F., & Sun, T. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.743726 · Cited by 121
Effect of Temperature on Cystic Fibrosis Lung Disease and Infections: A Replicated Cohort Study
Collaco, J. M., McGready, J., Green, D., Naughton, K., Watson, C., Shields, T., Bell, S. C., Wainwright, C. E., & for the ACFBAL Study Group, G. R. C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027784 · Cited by 120
Recent advances in the detection of repeat expansions with short-read next-generation sequencing
Bahlo, M., Bennett, M. F., Degorski, P., Tankard, R. M., Delatycki, M. B., & Lockhart, P. J. (2018) · F1000Research · doi:10.12688/f1000research.13980.1 · Cited by 117
Mutations in the noncoding genome
Scacheri, C., & Scacheri, P. C. (2015) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000283 · Cited by 116
Huntington disease reduced penetrance alleles occur at high frequency in the general population
Kay, C., Collins, J. A., Miedzybrodzka, Z., Madore, S. J., Gordon, E. S., Gerry, N. P., Davidson, M., Slama, R., & Hayden, M. R. (2016) · Neurology · doi:10.1212/wnl.0000000000002858 · Cited by 116
Identification of cis-suppression of human disease mutations by comparative genomics
Task Force for Neonatal Genomics, Jordan, D. M., Frangakis, S. G., Golzio, C., Cassa, C. A., Kurtzberg, J., Davis, E. E., Sunyaev, S. R., & Katsanis, N. (2015) · Nature · doi:10.1038/nature14497 · Cited by 115
Cis-regulatory mutations in human disease
Epstein, D. J. (2009) · Briefings in Functional Genomics and Proteomics · doi:10.1093/bfgp/elp021 · Cited by 113
Correa, H. (2016) · Journal of Pediatric Genetics · doi:10.1055/s-0036-1579759 · Cited by 111
Mechanisms of mutational robustness in transcriptional regulation
Payne, J. L., & Wagner, A. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00322 · Cited by 109
The central role of DNA damage and repair in CAG repeat diseases
Massey, T. H., & Jones, L. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.031930 · Cited by 109
Is population structure in the genetic biobank era irrelevant, a challenge, or an opportunity?
Lawson, D. J., Davies, N. M., Haworth, S., Ashraf, B., Howe, L., Crawford, A., Hemani, G., Davey Smith, G., & Timpson, N. J. (2020) · Human Genetics · doi:10.1007/s00439-019-02014-8 · Cited by 109
Goodrich, J. K., Singer‐Berk, M., Son, R. G., Sveden, A., Wood, J. C., England, E. M., Cole, J. B., Weisburd, B., Watts, N., Caulkins, L., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23556-4 · Cited by 108
KAT6A Syndrome: genotype–phenotype correlation in 76 patients with pathogenic KAT6A variants
Kennedy, J., Goudie, D., Blair, E., Chandler, K., Joss, S., McKay, V., Green, A., Armstrong, R., Lees, M., Kamien, B., et al. (2019) · Genetics in Medicine · doi:10.1038/s41436-018-0259-2 · Cited by 107
Lessons from studying monogenic disease for common disease
Peltonen, L., Perola, M., Naukkarinen, J., & Palotie, A. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl060 · Cited by 105 · cited 1×
“Deleterious variants in genes causative of monogenic disease can be further dysregulated by non-coding variants that are associated with common traits, and monogenic forms of numerous common complex diseases have been identified (Peltonen et al., 2006; Chami et al., 2020; Hassanin et al., 2021).”
BackgroundThe background puzzle: how identical mutations in the same gene lead to different disease symptoms
Kammenga, J. E. (2017) · FEBS Journal · doi:10.1111/febs.14080 · Cited by 105
Association of modifiers and other genetic factors explain Marfan syndrome clinical variability
Aubart, M., Gazal, S., Arnaud, P., Benarroch, L., Gross, M., Buratti, J., Boland, A., Meyer, V., Zouali, H., Hanna, N., et al. (2018) · European Journal of Human Genetics · doi:10.1038/s41431-018-0164-9 · Cited by 104
Cellular variability of nonsense-mediated mRNA decay
Sato, H., & Singer, R. H. (2021) · Nature Communications · doi:10.1038/s41467-021-27423-0 · Cited by 104
Mirshahi, U. L., Colclough, K., Wright, C. F., Wood, A. R., Beaumont, R. N., Tyrrell, J., Laver, T. W., Stahl, R. C., Golden, A. M., Goehringer, J., et al. (2022) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2022.09.014 · Cited by 104
Self-citationPhenotype-Specific Enrichment of Mendelian Disorder Genes near GWAS Regions across 62 Complex Traits
Freund, M. K., Burch, K. S., Shi, H., Mancuso, N., Kichaev, G., Garske, K. M., Pan, D. Z., Miao, Z., Mohlke, K. L., Laakso, M., et al. (2018) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2018.08.017 · Cited by 102
Wallis, G. A., Starman, B. J., Zinn, A. B., & Byers, P. H. (1990) · PubMed · Cited by 100
Incomplete penetrance in primary immunodeficiency: a skeleton in the closet
Gruber, C., & Bogunovic, D. (2020) · Human Genetics · doi:10.1007/s00439-020-02131-9 · Cited by 97 · cited 3×
“As these three are likely to be caused by overlapping or similar mechanisms (Gruber and Bogunovic, 2020), especially in genetically heterogenous conditions, we will discuss them together in this review.”
BackgroundInfluentialNeural Glycosylphosphatidylinositol-Anchored Proteins in Synaptic Specification
Um, J. W., & Ko, J. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.06.007 · Cited by 96
Visualizing the Role of Boundary Elements in Enhancer-Promoter Communication
Yokoshi, M., Kazuma, S., & Fukaya, T. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.02.007 · Cited by 96
Haeri, M., & Knox, B. E. (2012) · PubMed Central · Cited by 95
Role of Titin Missense Variants in Dilated Cardiomyopathy
Begay, R. L., Graw, S. L., Sinagra, G., Merlo, M., Slavov, D., Gowan, K., Jones, K. L., Barbati, G., Spezzacatene, A., Brun, F., et al. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.002645 · Cited by 95
Cited by
Schubach, M., Maass, T., Nazaretyan, L., Röner, S., & Kircher, M. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkad989 · Cited by 455
QSOX2 Deficiency-induced short stature, gastrointestinal dysmotility and immune dysfunction
Maharaj, A. V., Ishida, M., Rybak, A., Elfeky, R., Andrews, A., Joshi, A., Elmslie, F., Joensuu, A., Kantojärvi, K., Jia, R. Y., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52587-w · Cited by 9
Jenkins, D. (2024) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2023.0045 · Cited by 6
Metadata
- Authors
- Kingdom, R., & Wright, C. F.
- Venue
- Frontiers in Genetics
- Publisher
- Frontiers Media SA
- Published
- 2022-07-25
- Volume
- 13
- Pages
- 920390-920390
- ISSN
- 1664-8021 (ISSN-L)
- OpenAlex
- W4287218243
- Cited by
- 287
- References
- 331
- FWCI
- 28.00
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.